tricuspid

Comienza a surgir evidencia positiva para la “válvula olvidada”

New Light on the Forsaken Valve

Tricuspid regurgitation&nbsp;is frequent and mostly secondary to right ventricle and tricuspid annulus dilation. Tricuspid regurgitation has been associated to mortality increase, even though historically the importance of this&nbsp;valve&nbsp;has been disregarded compared to the other three. Tricuspid surgical repair has seen good results, but it is mostly done in the context of another valve repair. Isolated<a href="https://solaci.org/en/2017/08/28/new-light-on-the-forsaken-valve/" title="Read more" >...</a>

El reemplazo transcatéter en válvulas bicúspides suma evidencia pero continúan los desafíos

Transcatheter valve replacement in the bicuspid valve is increasingly performed, but challenges remain

As experience increases,&nbsp;transcatheter aortic valve replacement (TAVR)&nbsp;has expanded to different populations and anatomies. This study sought to compare technical and clinical outcomes in patients with bicuspid versus tricuspid aortic stenosis from the&nbsp;Bicuspid AS TAVR Multicenter Registry. &nbsp; Outcomes of 561&nbsp;patients with bicuspid valves and 4546&nbsp;patients with tricuspid valves were compared. Propensity score matching was used<a href="https://solaci.org/en/2017/07/05/transcatheter-valve-replacement-in-the-bicuspid-valve-is-increasingly-performed-but-challenges-remain/" title="Read more" >...</a>

Más evidencia positiva para tratar prótesis biológicas disfuncionantes con la prótesis balón expandible

Further Evidence on Managing Dysfunctioning Bioprostheses with Balloon-Expandable Prostheses

Early experience with the valve-in-valve technique in the treatment of failed bioprosthetic surgical valves in transcatheter aortic valve replacement (TAVR) has yielded acceptable acute procedural results. This turned the technique into another therapeutic option, one that could even cause the reassessment of the age limit for the surgical implantation of a mechanical or bioprosthesis valve.<a href="https://solaci.org/en/2017/05/17/further-evidence-on-managing-dysfunctioning-bioprostheses-with-balloon-expandable-prostheses/" title="Read more" >...</a>

Válvula Bicúspide

Bicuspid Aortic Valve Stenosis Still Challenging for TAVR

Courtesy of Dr. Carlos Fava One of the present challenges of TAVR is bicuspid aortic valve stenosis (AS), since it presents a different distribution and structure, associated to greater and more irregular calcification. There are only small series of devices and their use is still controversial. &nbsp; The study analyzed 561 patients with severe bicuspid<a href="https://solaci.org/en/2017/04/27/bicuspid-aortic-valve-stenosis-still-challenging-for-tavr/" title="Read more" >...</a>

anuloplastia mitral percutánea

Percutaneous Mitral Annuloplasty: First Results in Humans

&nbsp;Courtesy of Dr.&nbsp;Agustín&nbsp;Vecchia.&nbsp; In the last few years, new percutaneous treatment options for mitral regurgitation have emerged. Transcatheter mitral annuloplasty with various devices is a relatively simple procedure that could compress the origin of circumflex artery branches due to the different orientation of mitral corners and the coronary sinus. &nbsp; The following work by Park<a href="https://solaci.org/en/2017/03/27/percutaneous-mitral-annuloplasty-first-results-in-humans/" title="Read more" >...</a>

tavr insuficiencia aórtica pura

TAVR in Pure Aortic Insufficiency: Yes or No?

Courtesy of Dr.&nbsp;Agustín&nbsp;Vecchia. Surgery is the treatment of choice for patients with symptomatic aortic insufficiency and/or ventricular dilatation or decreased ventricular function. The broad implementation of transcatheter aortic valve replacement (TAVR) in patients with aortic stenosis, the emergence of new devices, and the experience acquired by operators have brought this treatment to off-label indications such<a href="https://solaci.org/en/2016/12/13/tavr-in-pure-aortic-insufficiency/" title="Read more" >...</a>

TAVR with Sapien XT: similar to surgical replacement in intermediate risk patients

Original Title: Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk Patients. PARTNER 2A. Reference: Martin B. Leon et al. NEJM April 2, 2016 Courtesy of Dr. Juan A. Terré Studies have shown mortality rates after transcatheter aortic valve replacement (TAVR) and surgical aortic valve replacement (SAVR) in high risk patients are similar (PARTNER 2 Cohort B). This is<a href="https://solaci.org/en/2016/04/15/tavr-with-sapien-xt-similar-to-surgical-replacement-in-intermediate-risk-patients/" title="Read more" >...</a>

Magazines

JSHD | JOURNAL OF STRUCTURAL HEART DISEASE The scope of the Journal of Structural Heart Disease includes all adults with structural and congenital heart diseases, including imaging related to interventional therapies in structural and congenital heart disease. Principal subjects of the journal include the aortic valve, the aortic arch, the mitral valve, the left atrial<a href="https://solaci.org/en/2015/07/13/magazines/" title="Read more" >...</a>

Transcatheter valve replacement for bicuspid aortic valve stenosis

Original title:&nbsp;Comparison of Results of Transcatheter Aortic Valve Implantation in Patients with Severely Stenotic Bicuspid versus Tricuspid or Non-Bicuspid Valves.&nbsp;Reference:&nbsp;Charis Costopoulos et al. Am J Cardiol. 2014 Jan 31. pii: S0002-9149(14)00554-2. &nbsp; The bicuspid aortic valve (BAV) is the most common congenital cardiac malformation. It occurs in approximately 1% of the general population and often<a href="https://solaci.org/en/2014/03/11/n-4327/" title="Read more" >...</a>

Top